Bridging the “Pharma-Startup Gap”: How Can Pharma Companies and Digital-Health Startups Work Effectively to Bring Products to Market Faster
Dec 29, 2022
auto_awesome
Naomi Fried, CEO and Founder of PharmStars, discusses bridging the "Pharma-Startup Gap" and the three biggest mistakes digital health startups make when approaching pharma companies. They also explore the challenges pharma faces when engaging with startups and the potential for startups to strike a seven-figure deal with pharma in seven months.
Startups need to understand pharma's needs and challenges to effectively communicate their value proposition.
Collaboration between startups and pharma can span the entire value chain, bringing innovation and value creation to both sides.
Deep dives
Bridging the Pharma-Startup Gap
Naomi Fried, founder and CEO of Farmstars, discusses the need to bridge the gap between startups and pharmaceutical companies. Many startups have great ideas that could benefit pharma, but they struggle to effectively communicate their value proposition. Fried emphasizes the importance of startups understanding pharma's needs and challenges, and tailoring their solutions accordingly. One of the key mistakes startups make is not articulating their pharma value proposition, which puts the burden on pharma to figure out how the solution fits their needs. Fried also highlights the differences in approach between startups and pharma in terms of innovation, risk appetite, and timing. The goal of Farmstars is to facilitate a constructive collaboration between startups and pharma, so that they can overcome these differences and work together to drive innovation in the pharmaceutical industry.
Opportunities for Collaboration
Digital health startups have a lot to offer pharma in terms of innovation and value creation. One key area of collaboration is in providing more value to patients through the combination of drugs and digital solutions, such as apps, diagnostics, and digital therapeutics. Startups can also support pharma in the drug discovery and development process by offering platform tools, data analytics, and solutions for clinical trials. Additionally, digital diagnostics can facilitate precision medicine by tailoring therapeutics to specific patients. The potential for collaboration between startups and pharma spans the entire value chain, from drug discovery to commercialization, and can bring significant benefits to both sides.
Challenges and Mistakes
Both startups and pharma face challenges when trying to work together effectively. Startups often make mistakes such as not understanding pharma's needs and not speaking the language of pharma. They may not have a clear pharma value proposition or a deep understanding of how pharma is organized. On the other hand, pharma sometimes lacks clarity of purpose and struggles to fully appreciate the urgency and speed with which startups need to operate. They may also fail to understand the resource constraints of startups and the need for a more streamlined decision-making process. Recognizing and addressing these challenges is crucial for successful collaboration between startups and pharma.
Success Stories and Synergies
Through Farmstars, Naomi Fried has witnessed several success stories of startups successfully collaborating with pharma. By providing startups with support and empowering them with knowledge about pharma, Farmstars has helped startups develop strong pharma value propositions and engage in fruitful conversations with pharma companies. Startups have reported feeling more confident and empowered in discussions with pharma after gaining a better understanding of pharma's expectations and language. The synergy between the Farmstars accelerator and AMBIT Health Ventures, a venture fund focused on digital health startups, allows for a more comprehensive support system for startups, combining funding opportunities with strategic guidance and advice.
Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide
In this episode, Bozidar is joined by Naomi Fried, CEO and Founder of PharmStars.
They cover:
What is the Pharma-Startup Gap and how to bridge it?
What are the three biggest mistakes that digital health startups make when approaching pharma companies?
Are digital health founders coming from the pharma industry, or are they newcomers?
What is the number one challenge that pharma faces when engaging with startups?
Can startups strike a seven-figure deal with pharma in seven months?
“Pharma Launch Secrets” is a podcast by Evermed and hosted by CEO Bozidar Jovicevic. We host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.